FibroBiologics, Inc.
FBLG
$0.8762
$0.00120.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -519.80% | -155.68% | 110.61% | 12.94% | -343.29% |
| Total Depreciation and Amortization | 6.99% | 2.14% | 2.19% | 5.38% | 16.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.89% | 36.05% | -195.01% | -52.67% | 1,654.69% |
| Change in Net Operating Assets | -534.09% | -109.50% | 10.50% | 31.76% | -36.90% |
| Cash from Operations | -17.92% | -33.85% | 54.46% | -167.02% | -40.56% |
| Capital Expenditure | -800.00% | 83.33% | -725.00% | -300.00% | 99.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -800.00% | 83.33% | -725.00% | -300.00% | 99.52% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 33.14% | 0.00% | -49.57% | -- | -- |
| Issuance of Common Stock | -99.03% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.68% | 2,699.42% | -105.25% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 232.15% | 184.85% | -117.41% | 37.31% | -161.93% |
